According to some Researches "By 2030, the global personalized skincare market is projected to surpass $45 billion—a testament to a revolution driven not by fleeting trends, but by data, AI, DNA, and ...

Scientists are using ancient DNA and gene editing to bring back woolly mammoths—possibly by 2028. This controversial project ...

Scientists have discovered a new type of immune defense in E. coli bacteria that turns viral infection machinery against the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...

As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...

One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

The central peak of Gale Crater was about 5 kilometers tall, created by the ancient meteorite impact. The Curiosity mission started near the bottom of the crater, at the base of a formation called ...

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...

Against the ancient backdrop of Rome’s Colosseum, thousands gathered Friday evening for the solemn Via Crucis procession, where Cardinal Baldassare Reina carried the cross on behalf of Pope ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...